Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Parry J Guilford

8PUBLICATIONS

18CO-AUTHORS

Cancer geneticsPredictive and prognostic markersMolecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jan 10, 2026

The Changing Landscape of Hereditary Diffuse Gastric Cancer.

Conor Vaessen, Kieran Redpath, Emily Schulpen

|Sep 29, 2024

Blending space and time to talk about cancer in extended reality.

Tamsin J Robb, Yinan Liu, Braden Woodhouse

|Sep 28, 2024

Analytical Validation of Cxbladder<sup>®</sup> Detect, Triage, and Monitor: Assays for Detection and Management of Urothelial Carcinoma.

Justin C Harvey, Lisa M Cambridge, Charles W Ellen

|Apr 12, 2022

E-Cadherin-Deficient Cells Are Sensitive to the Multikinase Inhibitor Dasatinib.

Nicola Bougen-Zhukov, Lyvianne Decourtye-Espiard, Wilson Mitchell

|Jan 11, 2022

E-Cadherin-Deficient Epithelial Cells Are Sensitive to HDAC Inhibitors.

Lyvianne Decourtye-Espiard, Nicola Bougen-Zhukov, Tanis Godwin

|Jan 11, 2022

Loss of E-Cadherin Leads to Druggable Vulnerabilities in Sphingolipid Metabolism and Vesicle Trafficking.

Tom Brew, Nicola Bougen-Zhukov, Wilson Mitchell

Pageof 2

Frequent Collaborators

3 joint publications

Nicola Bougen-Zhukov

2 joint publications

Tom Brew

2 joint publications

Michael A Black

1 joint publications

Tanis Godwin

1 joint publications

Christopher Hakkaart

1 joint publications

Lyvianne Decourtye-Espiard

1 joint publications

Tamsin J Robb

1 joint publications

Braden Woodhouse

1 joint publications

Charlotta Windahl

1 joint publications

Grant McArthur

Frequent Collaborators

3 joint publications

Nicola Bougen-Zhukov

2 joint publications

Tom Brew

2 joint publications

Michael A Black

1 joint publications

Tanis Godwin

Top Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

Three-Dimensional Imaging of Tumor-Bearing Tissue Using the Iterative Bleaching Extends Multiplexity Approach

Three-Dimensional Imaging of Tumor-Bearing Tissue Using the Iterative Bleaching Extends Multiplexity Approach

Published on : Apr 25, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

See more related videos

Top Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

Three-Dimensional Imaging of Tumor-Bearing Tissue Using the Iterative Bleaching Extends Multiplexity Approach

Three-Dimensional Imaging of Tumor-Bearing Tissue Using the Iterative Bleaching Extends Multiplexity Approach

Published on : Apr 25, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

See more related videos